Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer K Mathur

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology|March 19, 2015
Severity of virus-induced asthma symptoms is inversely related to resolution IFN-λ expressionElizabeth A Schwantes, Loren C Denlinger, Michael D Evans, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 7, 2020
Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthmaZenobia Dotiwala, Julian Casciano, Jill R Davis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 2022
Omalizumab for treatment of idiopathic angioedemaVinay P Goswamy, Kristine E Lee, Elizabeth M McKernan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 16, 2024
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United StatesSameer K Mathur, Jared Silver, Sean D MacKnight, et al.
Drug Safety|April 4, 2020
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on BenralizumabDavid J Jackson, Stephanie Korn, Sameer K Mathur, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2016
Role of food and aeroallergen sensitization in eosinophilic esophagitis in adultsAshleigh A Olson, Michael D Evans, Mats W Johansson, et al.
Journal of Asthma and Allergy|January 4, 2018
Elevated fractional exhaled nitric oxide and blood eosinophil counts are associated with a 17q21 asthma risk allele in adult subjectsElizabeth A Schwantes, Michael D Evans, Alex Cuskey, et al.
Allergy and Asthma Proceedings|May 17, 2020
Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthmaBradley Chipps, Giselle Mosnaim, Sameer K Mathur, et al.
Annual Review of Immunology|March 1, 2021
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological TherapiesElizabeth A Jacobsen, David J Jackson, Enrico Heffler, et al.
Cells|June 10, 2022
Autophagy Protects against Eosinophil Cytolysis and Release of DNAStephane Esnault, Paul S Fichtinger, Karina T Barretto, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology|March 19, 2015
Severity of virus-induced asthma symptoms is inversely related to resolution IFN-λ expressionElizabeth A Schwantes, Loren C Denlinger, Michael D Evans, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 7, 2020
Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthmaZenobia Dotiwala, Julian Casciano, Jill R Davis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 2022
Omalizumab for treatment of idiopathic angioedemaVinay P Goswamy, Kristine E Lee, Elizabeth M McKernan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 16, 2024
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United StatesSameer K Mathur, Jared Silver, Sean D MacKnight, et al.
Drug Safety|April 4, 2020
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on BenralizumabDavid J Jackson, Stephanie Korn, Sameer K Mathur, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2016
Role of food and aeroallergen sensitization in eosinophilic esophagitis in adultsAshleigh A Olson, Michael D Evans, Mats W Johansson, et al.
Journal of Asthma and Allergy|January 4, 2018
Elevated fractional exhaled nitric oxide and blood eosinophil counts are associated with a 17q21 asthma risk allele in adult subjectsElizabeth A Schwantes, Michael D Evans, Alex Cuskey, et al.
Allergy and Asthma Proceedings|May 17, 2020
Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthmaBradley Chipps, Giselle Mosnaim, Sameer K Mathur, et al.
Annual Review of Immunology|March 1, 2021
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological TherapiesElizabeth A Jacobsen, David J Jackson, Enrico Heffler, et al.
Cells|June 10, 2022
Autophagy Protects against Eosinophil Cytolysis and Release of DNAStephane Esnault, Paul S Fichtinger, Karina T Barretto, et al.
Pageof 7